Apertus Pharmaceuticals manufactures Active Pharmaceutical Ingredients (APIs) and is a supplier to pharmaceutical companies that make finished products.  Apertus provides bulk controlled APIs (Schedule II – V), non-controlled APIs, and analytical methods development to the pharmaceutical market.  In addition, Apertus performs research and development services, such as specialty chemical synthesis, process improvement, and analytical chemistry services.  Apertus is committed to products with superior quality and purity, and practices the philosophy of Green Chemistry as outlined by FDA.

Apertus Pharmaceuticals is dedicated to delivering products that provide the highest quality combined with value pricing. We wish to establish successful partnerships with clients and vendors that respect both the interests and goals of each party.  Apertus Pharmaceuticals will strive to exceed the expectations of customers with excellent prices, service, and expertise.

Products

The primary products that Apertus Pharmaceuticals offers are Active Pharmaceutical Ingredients (API) for controlled substances and non-controlled substance.  Additionally, Apertus Pharmaceuticals will conduct research to develop new manufacturing processes, new API Derivatives and expanded delivery methods for existing API.

• Controlled Substance API
• Non-controlled API
• New Process Development leading to Intellectual Property
• New Delivery Methods
• Analytical Methods Development

All products and processes are developed and executed under cGMP/ICH guidelines, allowing for the use of any of our products world-wide.